Loading: 100%
Jazz Pharmaceuticals plc logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 1,040 (as per Q3 2016)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker JAZZno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17100120140160180
datesClosing price (adj.)
13.10.2017141.38
11.10.2017142.57
04.10.2017150.39
27.09.2017148.16
20.09.2017151.18
13.09.2017152.68
06.09.2017148.60
30.08.2017145.94
23.08.2017146.50
16.08.2017147.40
09.08.2017142.90
02.08.2017150.41
26.07.2017161.52
19.07.2017156.14
12.07.2017155.93
05.07.2017155.75
27.06.2017154.86
20.06.2017152.25
13.06.2017149.49
06.06.2017145.19
30.05.2017148.17
23.05.2017150.61
16.05.2017151.29
09.05.2017158.35
02.05.2017159.71
25.04.2017154.90
18.04.2017152.11
11.04.2017152.98
04.04.2017143.21
28.03.2017145.91
21.03.2017142.95
14.03.2017136.89
07.03.2017132.99
28.02.2017132.62
21.02.2017135.93
14.02.2017133.78
07.02.2017125.05
31.01.2017121.92
24.01.2017120.19
17.01.2017115.57
10.01.2017116.12
03.01.2017111.46
27.12.2016112.20
19.12.2016107.12
12.12.2016102.70
05.12.2016101.62
28.11.2016108.04
21.11.2016110.53
14.11.2016112.86
07.11.2016107.51
31.10.2016109.47
24.10.2016118.91
17.10.2016117.69
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
141.38n/a
Market Capitalisation
in million USD
8,468n/a
Enterprise Value
in million USD
10,225n/a
Common Shares Outstanding
as per Oct 31, 2016
59,892,335n/a
Preferred Shares Outstanding
as per Oct 31, 2016
n/a
Average Basic Shares Outstanding
TTM
60,894,000n/a
Average Diluted Shares Outstanding
TTM
62,221,250n/a
Index Membership
n/a
Business Summary
Jazz Pharmaceuticals PLC is a biopharmaceutical company focused on improving patients\' lives by identifying, developing and commercializing differentiated products that address unmet medical needs.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 1,432n/a
Gross Profit 1,432n/a
Operating Income 533n/a
EBITDA 643n/a
Net Profit 355n/a
Balance Sheet
Cash and Cash Equivalents 426n/a
Receivables 238n/a
Total Current Assets 744n/a
PP&E 100n/a
Total Assets 4,931n/a
Accounts Payable 18n/a
Current Debt 36n/a
Total Current Liabilities 233n/a
Long-Term Debt 2,147n/a
Total Liabilities 3,215n/a
Total Equity 1,715n/a
Cash Flow
Depreciation & Amortisation 110n/a
Change in Working Capital -62n/a
Operating Cash Flow 530n/a
Net Change in PP&E and Intangibles -184n/a
Investing Cash Flow -1,751n/a
Dividends Paid 0n/a
Financing Cash Flow 589n/a
Total Change in Cash -632n/a
Free Cash Flow 275n/a
Profitability Ratios
Gross Margin 100.0%n/a
Operating Margin 37.2%n/a
Net Profit Margin 24.8%n/a
Return on Equity 20.7%n/a
Return on Assets 7.2%n/a
Per Share Figures
Basic EPS 5.83n/a
Diluted EPS 5.71n/a
Sales per Share 23.52n/a
Book Value per Share 28.17n/a
FCF per Share 4.52n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 24.23n/a
Price to Sales Ratio 6.01n/a
Price to Book Value 5.02n/a
Price to Free Cash Flow 31.27n/a
Valuation Metrics
EV/EBITDA 15.90n/a
EV/Sales 7.14n/a
Book to Market Value 0.20n/a
Other Ratios
Current Ratio 319.6%n/a
Liabilities to Equity Ratio 187.4%n/a
Debt to Assets Ratio 44.3%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
128
174
272
586
872
1,173
1,325
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
0
0
0
0
0
0
0
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
128
174
272
586
872
1,173
1,325
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-113
-116
-144
-388
-532
-977
-817
Selling, General & Administrative
-59
-69
-109
-224
-304
-406
-449
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-37
-26
-14
-20
-42
-85
-135
Depreciation & Amortization
-8
-8
-7
-65
-79
-127
-98
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
-10
-14
-14
-78
-107
-359
-134
Operating Income (Loss)
16
58
128
198
340
196
508
Non-Operating Income (Loss)
-23
-13
-2
-20
-29
-44
-55
Interest Expense, net
-23
-13
-2
-17
-27
-53
-57
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
-4
-2
9
1
Pretax Income (Loss), Adjusted
-7
45
126
177
312
152
453
Abnormal Gains (Losses)
0
-12
-1
0
-4
0
-17
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
-7
33
125
177
308
152
436
Income Tax (Expense) Benefit, net
0
0
0
84
-92
-94
-106
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-7
33
125
261
216
57
330
Net Extraordinary Gains (Losses)
0
0
0
27
0
0
0
Discontinued Operations
0
0
0
27
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-7
33
125
289
216
57
330
Minority Interest
0
0
0
0
0
1
0
Net Income
-7
33
125
289
216
58
330
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-7
33
125
289
216
58
330
Remarks
restated on Feb 28, 2012 n/a
calculated values,
restated on Feb 26, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 24, 2015 n/a
calculated values,
restated on Feb 23, 2016 n/a
calculated values,
restated on Feb 23, 2016 n/a
calculated values,
restated on Feb 23, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
45
158
387
637
684
989
Cash & Cash Equivalents
n/a
45
82
387
637
684
989
Short Term Investments
n/a
0
76
0
0
0
0
Accounts & Notes Receivable
n/a
22
34
75
125
186
210
Accounts Receivable, Net
n/a
22
34
75
125
186
210
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
5
4
27
29
30
19
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
3
3
62
75
115
40
Prepaid Expenses
n/a
2
2
7
7
13
21
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
33
0
Deferred Tax Assets
n/a
0
0
36
34
48
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
1
1
19
34
21
19
Total Current Assets
n/a
74
199
552
865
1,016
1,258
Property, Plant & Equipment, Net
n/a
1
2
7
14
58
86
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
61
53
1,408
1,359
2,265
2,000
Intangible Assets
n/a
22
15
870
812
1,437
1,186
Goodwill
n/a
38
38
443
450
703
657
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
75
75
75
123
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
20
22
49
35
Total Noncurrent Assets
n/a
61
54
1,415
1,374
2,323
2,086
Total Assets
n/a
136
254
1,966
2,238
3,339
3,344
Liabilities and owners' equity
Payables & Accruals
n/a
27 26621000
40 39912000
160 160437000
141 141059000
197 196805000
188 187685000
Accounts Payable
n/a
3 3049000
5 5129000
16 15887000
21 21005000
25 25126000
22 21807000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
24 23572000
35 34783000
145 144550000
120 120054000
172 171679000
166 165878000
Short Term Debt
n/a
16 16064000
0 0
30 29688000
6 5572000
9 9428000
38 37587000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
17 17251000
13 12958000
1 1413000
57 57397000
11 10568000
1 1370000
Deferred Revenue
n/a
1 1273000
1 1138000
1 1138000
1 1138000
1 1138000
1 1370000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 275000
6 6259000
9 9430000
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
16 15978000
12 11820000
0 0
50 50000000
0 0
0 0
Total Current Liabilities
n/a
60 59936000
53 52870000
192 191538000
204 204028000
217 216801000
227 226642000
Long Term Debt
n/a
25 24629000
0 0
427 427073000
544 544404000
1,333 1333000000
1,151 1150857000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
21 20613000
8 7915000
227 227116000
195 194781000
418 418472000
368 367985000
Accrued Liabilities
n/a
0 82000
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
9 9053000
8 7915000
7 6776000
6 5718000
4 4499000
4 3721000
Deferred Tax Liabilities
n/a
0 0
0 0
178 178393000
168 168497000
375 375054000
294 294485000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
11 11478000
0 0
42 41947000
21 20566000
39 38919000
70 69779000
Total Noncurrent Liabilities
n/a
45 45242000
8 7915000
654 654189000
739 739185000
1,751 1751472000
1,519 1518842000
Total Liabilities
n/a
105 105178000
61 60785000
846 845727000
943 943213000
1,968 1968273000
1,745 1745484000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
505 505417000
543 542701000
1,151 1151016000
1,220 1220323000
1,458 1458011000
1,563 1562906000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-475 -474866000
-350 -349882000
-61 -61296000
19 18532000
35 34704000
303 302686000
Other Equity
n/a
0 0
0 -31000
31 31046000
56 56153000
-122 -122097000
-267 -267472000
Equity Before Minority Interest
n/a
31 30551000
193 192788000
1,121 1120766000
1,295 1295008000
1,371 1370618000
1,598 1598120000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 64000
0 0
Total Equity
n/a
31 30551000
193 192788000
1,121 1120766000
1,295 1295008000
1,371 1370682000
1,598 1598120000
Total Liabilities & Equity
n/a
136 135729000
254 253573000
1,966 1966493000
2,238 2238221000
3,339 3338955000
3,344 3343604000
Remarks restated on n/a restated on Feb 28, 2012 n/a restated on Feb 26, 2013 n/a restated on Feb 25, 2014 n/a restated on Feb 24, 2015 n/a restated on Feb 23, 2016 n/a restated on Nov 8, 2016 n/a
Cash Flow StatementCF data quality: 93% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-7
33
125
289
216
57
330
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
9
9
8
74
82
134
108
Non-Cash Items
9
23
22
-108
71
281
100
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
-27
-6
-4
-5
-81
-66
-6
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
-16
59
152
250
288
406
532
Change in Fixed Assets & Intangibles
-6
-5
-1
-6
-16
-239
-36
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
1
0
-76
76
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
-449
0
-829
34
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
-1
3
-4
-17
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
-6
-2
-81
-395
-16
-1,068
-2
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
6
-81
-49
439
88
885
-167
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
7
62
16
25
-106
16
-21
Increase in Capital Stock
7
62
16
25
31
58
41
Decrease in Capital Stock
0
0
0
0
-136
-42
-62
Other Financing Activities
0
-8
0
-16
-6
-188
-26
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
13
-28
-33
449
-24
713
-214
Net Cash Before Disc. Operations and FX
-9
29
37
303
248
51
315
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
-9
29
37
303
248
51
315
Effect of Foreign Exchange Rates
0
0
0
2
1
-3
-11
Net Changes in Cash
-9
29
37
305
249
48
305
Remarks
restated on Feb 28, 2012 n/a
calculated values,
restated on Feb 26, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 24, 2015 n/a
calculated values,
restated on Feb 23, 2016 n/a
calculated values,
restated on Feb 23, 2016 n/a
calculated values,
restated on Feb 23, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo